Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease-Reference-Cited by-同舟云学术

Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease

Published:2022-04-22 Issue:1 Volume:68 Page:65-76
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Forss Anders^ORCID,Clements Mark,Myrelid Pär,Strid Hans,Söderman Charlotte,Wagner Agnieszka,Andersson David,Hjelm Fredrik,Olén Ola,Halfvarson Jonas,Ludvigsson Jonas F.,

Funder

Janssen Cilag AB

Karolinska Institute

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-022-07501-z.pdf

Reference33 articles.

1. Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet 2012;380:1590–1605.

2. Olen O, Erichsen R, Sachs MC, et al. Colorectal cancer in Crohn’s disease: a Scandinavian population-based cohort study. Lancet Gastroenterol. Hepatol. 2020;5:475–484.

3. Olen O, Askling J, Sachs MC, et al. Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964–2014. Gut. 2020;69:453–461.

4. Khalili H, Everhov AH, Halfvarson J, et al. Healthcare use, work loss and total costs in incident and prevalent Crohn’s disease and ulcerative colitis: results from a nationwide study in Sweden. Aliment Pharmacol. Ther. 2020;52:655–668.

5. Everhov AH, Halfvarson J, Myrelid P, et al. Incidence and treatment of patients diagnosed with inflammatory bowel diseases at 60 years or older in Sweden. Gastroenterology. 2018;154:518–528.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-year Safety and Effectiveness of Ustekinumab in Patients With Crohn’s Disease: The K-STAR Study;Inflammatory Bowel Diseases;2024-08-03

2. O USO DO VEDOLIZUMBABE NO TRATAMENTO DA DOENÇA DE CRONH: UMA REVISÃO INTEGRATIVA;REVISTA FOCO;2024-07-02

3. Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn’s disease patients over three years;Scientific Reports;2024-06-28

4. Real-world clinical effectiveness of ustekinumab in the treatment of Crohn’s disease in the East Midlands UK;Frontline Gastroenterology;2024-06-14

5. Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn’s disease patients over three years;2024-03-13